Gestalt Diagnostics has obtained CE-IVD marks for two of the main components of PathFlow, its digital pathology solution.
The European regulatory approval for PathFlow’s viewer and automated workflow will enable its extensive use in education, clinical and research labs.
The easy-to-use, cloud-based digital pathology PathFlow platform can be easily customised for specific preferences.
It allows pathologists to interpret results and diagnose patient cases quickly, efficiently and in a completely automated way.
PathFlow’s viewer and automated workflow components will help healthcare facilities deploy and recognise the advantages of digital pathology throughout their organisations.
Using the viewer, pathologists or researchers can access all the information related to their study, case or course in a single workflow.
It remains consistent throughout all the PathFlow modules.
PathFlow’s automated workflow also enables the automatic routing of cases to a pathologist’s worklist depending on multiple lab (or customer) defined criteria.
Gestalt chief operating officer and chief strategy officer Lisa-Jean Clifford said: “A truly interoperable platform, which incorporates every component necessary to streamline the workflow for pathologists, is essential for leveraging the full benefits of digital pathology.
“The receipt of these CE-IVD marks is an important milestone for our company in providing the assurance that our solutions meet the regulatory standards required for patient care while increasing speed and efficiency for their providers.”
The company noted that its solutions are developed together with its advisory board of pathologists to ensure usability, features and functionality that will best support clinical workflows in the industry.